JPM

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

1 month ago   |   Xconomy

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a...
Read more ...

JPM: Biotech, VC execs on where the industry should look beyond cancer

1 month ago   |   Fierce Biotech

SAN FRANCISCO-Oncology is clearly a major medical and societal issue: a major killer that, while predominately affecting the older population, can strike the young through a...
Read more ...

Video Replay: Endpoints at JPM20 - newsmakers on dealmaking, pricing and manufacturing

1 month ago   |   San Diego Biotechnology

On Monday, we held our fourth annual JPM event - and the team hit a key milestone that I'd like to share with the entire Endpoints News audience: We live-streamed the...
Read more ...

JPM Tuesday roundup: Pfizer CEO talks up pipeline, bolt-on deals the name of the game in 2020?

1 month ago   |   Fierce Biotech

SAN FRANCISCO-The second day of the annual J.P. Morgan Healthcare Conference again saw no major M&A deals but did see some of the bigger pharma companies present and talk a...
Read more ...

JPM: Mayo Clinic, nference launch ambitious data platform initiative

1 month ago   |   Fierce Biotech

SAN FRANCISCO-Just a week after backing its $60 million series B round, the Mayo Clinic has tapped healthcare data analytics firm nference to build out an artificial...
Read more ...

JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise

1 month ago   |   Fierce Biotech

SAN FRANCISCO-Well, let's start with the obvious, a pattern that has been set for a good few years now: There were no M&A deals on the so-called Merger Monday that typically...
Read more ...

JPM: As the biotech world makes San Francisco home for the week, Janssen has longer-term plans

1 month ago   |   Fierce Biotech   |   2 articles

As the annual J.P. Morgan Healthcare Conference kicks off in San Francisco this week, Janssen has unveiled plans to double down on its own long-term presence in the area.
Read more ...

JPM: No sleep, exiled mattresses, cleared bank accounts: Getting deals done at JPM

1 month ago   |   Fierce Biotech   |   2 articles

SAN FRANCISCO-We're always looking to ask the big questions at FierceBiotech, and, at this year's J.P. Morgan Healthcare Conference, we're asking: Where do all the orphaned...
Read more ...

Boundless Bio Announces Presentations at Two January Conferences

1 month ago   |   San Diego Biotechnology

SAN DIEGO--Boundless Bio announced presentations at the 2020 CTIC Pre-JPM 4th Healthcare Investment Summit and Precision Medicine World Conference....
Read more ...

FierceBiotech's top 10 stories of 2019-Gilead's failure, Biogen's phoenix, JPM venue fatigue and more

2 monthes ago   |   Fierce Biotech

As we reach the end of the year, we look back on the most read stories of the last 12 months as we also look ahead not just to a new year, but a new decade. So, what were the...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

IAmScience George Stewart

IAmScience George Stewart

By Becca Wolf | Bond LSC Medical bacteriologist, George Stewart has had a few stops along the way before he got to Bond LSC in 2004. Having done schooling and research at... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...